← Back to Patent Explorer
US4628052A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities

Assignee: Individual
•
Filing: 1985-05-28
•
Granted: 1986-12-09
•
Expires: 2005-05-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is concerned with compositions and methods of treating rheumatoid arthritis, osteoarthritis, and arthritis associated with psoriasis and with lupus and other auto-immune diseases, and also for treating non-specific joint pain associated with stress or incidental to another ailment, using dehydroepiandrosterone and/or other anesthetic steroids dissolved in an oily vehicle, and preferably administered topically or orally.

Inventors

  • 👤 Raymond F. Peat

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 13:25
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/565; A61K31/57

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 26 words
A method for treating arthritis and joint pain and disability, comprising administering to a patient in need of such treatment a pharmacologically effective dose of dehydroepiandrosterone.
Claim 2
Independent Claim 26 words
A method for treating arthritis and joint pain and disability, comprising administering to a patient in need of such treatment a pharmacologically effective dose of dehydroepiandrosterone.
Claim 3
Independent Claim 70 words
A method for treating arthritis, comprising administering to a patient in need of such treatment a pharmacologically effective dose of at least one compound selected from the group of the anesthetic class of naturally occurring steroids of the formula: ##STR2## wherein R 1 is O or OH and R 2 is O, OH, or COCH 3 ; and which may contain one double bond in ring A and/or ring B.
Claim 4
Independent Claim 70 words
A method for treating arthritis, comprising administering to a patient in need of such treatment a pharmacologically effective dose of at least one compound selected from the group of the anesthetic class of naturally occurring steroids of the formula: ##STR2## wherein R 1 is O or OH and R 2 is O, OH, or COCH 3 ; and which may contain one double bond in ring A and/or ring B.
Claim 5
Dependent Claim 22 words
The method of claim 2 in which said steroid is selected from the group consisting of: dehydroepiandrosterone, iso-androsterone, etiocholanolone, pregnenolone, and progesterone.
Claim 6
Dependent Claim 11 words
The method of claim 2 wherein the compound is administered orally.
Claim 7
Dependent Claim 11 words
The method of claim 2 wherein the compound is administered topically.
Claim 8
Dependent Claim 13 words
The method of claim 2, wherein the arthritis to be treated is osteo-arthritis.
Claim 9
Dependent Claim 14 words
The method of claim 2, wherein the arthritis to be treated is rheumatoid arthritis.
Claim 10
Dependent Claim 17 words
The method of claim 2, wherein the arthritis to be treated is arthritis associated with auto-immune disease.
Claim 11
Dependent Claim 21 words
The method of claim 2, wherein the condition to be treated comprises non-specific joint pain or joint disability resulting from stress.
Claim 12
Dependent Claim 61 words
A pharmaceutical composition useful for the treatment of arthritis comprising an effective amount of at least one compound selected from the group consisting of the formula: ##STR3## wherein R 1 is O or OH and R 2 is O, or OH; and which may contain one double bond in ring A and/or ring B and tocopherol, in a suitable pharmaceutical carrier.
Claim 13
Dependent Claim 61 words
A pharmaceutical composition useful for the treatment of arthritis comprising an effective amount of at least one compound selected from the group consisting of the formula: ##STR3## wherein R 1 is O or OH and R 2 is O, or OH; and which may contain one double bond in ring A and/or ring B and tocopherol, in a suitable pharmaceutical carrier.
Claim 14
Dependent Claim 25 words
The composition of claim 10 in which said steroid is selected from the group consisting of dehydroepiandrosterone, iso-androsterone, and etiochlolanolone, in a suitable pharmaceutical carrier.
Claim 15
Dependent Claim 13 words
The composition of claim 11 comprising an effective amount of dehydroepiandrosterone and tocopherol.
Claim 16
Dependent Claim 8 words
The composition of claim 11 also comprising progesterone.
Claim 17
Dependent Claim 8 words
The composition of claim 11 also comprising testosterone.
Claim 18
Dependent Claim 9 words
The composition of claim 11 also comprising olive oil.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-12-08 1990-06-09 1990-12-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-12-08 1994-06-09 1994-12-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-12-08 1998-06-09 1998-12-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag